US Stock MarketDetailed Quotes

OFIX Orthofix Medical

Watchlist
  • 16.190
  • -0.160-0.98%
Close Oct 31 16:00 ET
  • 16.190
  • 0.0000.00%
Post 16:04 ET
618.05MMarket Cap-5075P/E (TTM)

About Orthofix Medical Company

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Company Profile

SymbolOFIX
Company NameOrthofix Medical
Listing DateApr 23, 1992
Issue Price12.00
Founded1987
CEOMr. Massimo Calafiore
MarketNASDAQ
Employees1634
Fiscal Year Ends12-31
Address3451 Plano Parkway
CityLewisville
ProvinceTexas
CountryUnited States of America
Zip Code75056
Phone1-214-937-2000

Company Executives

  • Name
  • Position
  • Salary
  • Massimo Calafiore
  • President and Chief Executive Officer
  • --
  • Julie B. Andrews
  • Chief Financial Officer
  • --
  • Jorge Andres Cedron
  • Chief Legal Officer
  • --
  • Lucas Vitale
  • Chief People and Business Operations Officer
  • --
  • Geoffrey C. Gillespie
  • Vice President and Corporate Controller
  • --
  • Michael M. Finegan
  • Chairman of the Board
  • --
  • Jason M. Hannon
  • Independent Director
  • 261.41K
  • Charles R. Kummeth
  • Independent Director
  • --
  • Alan L. Bazaar
  • Independent Director
  • --
  • Wayne C. Burris
  • Independent Director
  • 251.41K
  • Michael E. Paolucci
  • Independent Director
  • 261.41K
  • John B. Henneman, III
  • Independent Director
  • --
  • Shweta Singh Maniar
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data